THE
INDEX
BeatsAllHormonalFertilityMaternalCardioDiagnosticsMental healthLongevityCare infra
Cardio · Research

Original research in Cardio

In-depth pieces, taxonomies, and market analyses produced by The Index editorial team on this beat.

Featured · Cardiovascular

Semaglutide CV outcomes by sex in SELECT (n=17,604)

JACC prespecified sex-stratified analysis: semaglutide 2.4mg consistently reduces MACE in both sexes; women face higher baseline CV risk at equivalent BMI.

The Index Editorial·
Cardiovascular
Semaglutide in obesity-related HFpEF: sex-stratified efficacy

JACC pooled STEP-HFpEF analysis (n=1,145; 49.7% women): semaglutide produces greater weight loss in women (-9.6%) than men (-7.2%); symptom gains equal.

The Index Editorial·